Labskin On A Chip

Labskin-On-A-Chip to monitor real-time skin related diseases and Labskin-AI data analysis to predict the best course of treatment Integumen is [...]

Trading Update November 2018

Major Restructuring Causing Increased Growth The Company is pleased to announce the increased growth in product sales and contract test [...]

Artificially Intelligent Labskin

First laboratory-grown human-skin test service, to use artificial intelligence, to provide clinical validation for cosmetic, personal hygiene and skin care [...]

Trading Update August 2018

Chairman’s Statement Introduction Since Integumen’s  admission to trading on AIM in April 2017, the integration of multiple isolated and diverse [...]

Interim Results 2018

Integumen (LSE: SKIN), the non-animal-testing, skin care and cosmetic businesses developing and commercialising technologies and products for consumer use today [...]